Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: J Immunol. 2010 Mar 1;184(7):3450–3460. doi: 10.4049/jimmunol.0903831

Figure 6. CXCL10/IP10 is produced in the allograft recipient spleen by DCs and B cells, independent of NK cells.

Figure 6

(A) mRNA expression of CXCL10 was determined in allograft and isograft recipient spleens at various times post-transplant (n = 3–4/group). Data was analyzed as in 3A. (B) B cells and DCs were flow-sort purified as in 3B and CXCL10 mRNA expression was determined as described. (C) Wild-type allograft recipients were depleted of NK cells as described, and total spleen homogenates were taken at the times indicated for qRT-PCR analysis of CXCL10 expression. Data represent two individual experiments, n = 3–4/group; mean ± SEM.